SQUAWK/NEWS
Menu
Live News EQUITY L impact

NERVGEN PHARMA CORP files

Nervgen Pharma Corp submits filing to SEC. Filing details not specified.

NGEN

Filed: 2026-05-26 AccNo: 9999999995-26-001763 Size: 1 KB